News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
DURECT Corporation Appoints Matthew J. Hogan As Chief Financial Officer
September 12, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CUPERTINO, Calif., Sept. 12 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX - News), an emerging specialty pharmaceuticals company, announced today that Matthew J. Hogan has joined the Company as Chief Financial Officer.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Insights
Can Europe turn world-class science into world-class scale?
April 16, 2026
·
5 min read
·
Jennifer C. Smith-Parker
Funding
Revolution doubles stock offering target to $2B following pancreatic cancer win
April 16, 2026
·
1 min read
·
Tristan Manalac
Artificial intelligence
Novartis CEO joins Anthropic board, embedding AI in the heart of biopharma
April 16, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Astellas’ consolidation efforts to impact 50 Universal Cells employees
April 15, 2026
·
48 min read
·
BioSpace Editorial Staff
